Old Web
English
Sign In
Acemap
>
authorDetail
>
Ben Ebede
Ben Ebede
Pfizer
Transthyretin
Internal medicine
Medicine
Tafamidis
Biochemistry
4
Papers
85
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years
2020
Neurology and Therapy
Giampaolo Merlini
Teresa Coelho
Márcia Waddington Cruz
Huihua Li
Michelle Stewart
Ben Ebede
Show All
Source
Cite
Save
Citations (8)
1169Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy
2019
European Heart Journal
Perry M. Elliott
Brian M. Drachman
Stephen S. Gottlieb
James E. Hoffman
Scott L. Hummel
Daniel J. Lenihan
Ben Ebede
Balarama Gundapaneni
Jeffrey H. Schwartz
Marla B. Sultan
Salim Shah
Show All
Source
Cite
Save
Citations (6)
A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy
2019
Amyloid
Peter Huber
A. Flynn
Marla B. Sultan
Huihua Li
Denise Rill
Ben Ebede
Balarama Gundapaneni
Jeffrey H. Schwartz
Show All
Source
Cite
Save
Citations (8)
Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years
2017
Amyloid
Fabio Barroso
Daniel P. Judge
Ben Ebede
Huihua Li
Michelle Stewart
Leslie Amass
Marla B. Sultan
Show All
Source
Cite
Save
Citations (63)
1